Translational Development Acquisition Corp

Chart & performance

D1W1MN

P/E

—

P/S

—

EPS

0.26

Div yield, %

—

Shrs. gr., 5y

19.42%

Rev. gr., 5y

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Translational Development Acquisition Corp., established in 2022 and headquartered in New York, New York, currently possesses no significant business operations. Its primary objective is to finalize a strategic business combination, which could involve a merger, share exchange, asset acquisition, or reorganization, with one or more other entities.

URL

IPO date

Dec 23, 2024

Employees

Domiciled in

Incorporated in

Valuation

No data to show